treating crs and icans: current approaches and future outlooks
Published 1 year ago • 483 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
1:23
management of crs and icans after car-t therapy for all
-
5:54
investigating the co-occurrence of crs and icans after car-t therapy & the need for novel therapies
-
1:51
current treatment strategies for crs and insights into other car-related toxicities
-
3:32
improving car-t therapy for all & lymphoma: allogeneic products & reducing crs/icans
-
3:56
the future of cancer treatment is here: introducing proton therapy
-
7:46
immune effector cell associated neurotoxicity syndrome icans
-
58:43
“what you need to know right now” *pick a card* (timeless)
-
2:16
current and future treatment approaches for hr-mds
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
1:34
car-t expansion is associated with treatment response, crs, and cytopenia in patients with r/r mm
-
0:58
management strategies for acute and chronic gvhd following allosct
-
2:03
current soc for bpdcn and other emerging treatment options
-
3:47
update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
-
3:26
recent advances in the treatment of patients with myeloma: adcs, antibodies and car-t
-
1:22
safety and efficacy of cc-99282 in the treatment of r/r nhl
-
1:53
the future of multiple myeloma treatment
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
0:45
key trials in cll and designing a concept for treatment